We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

204 hedge funds and large institutions have $1B invested in Immunogen Inc in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 68 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $6.78M | Put options by funds: $3.42M

6% more capital invested

Capital invested by funds: $948M → $1B (+$55.2M)

1% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 68

8% less funds holding

Funds holding: 222204 (-18)

39% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 44

Holders
204
Holders Change
-18
Holders Change %
-8.11%
% of All Funds
3.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
27
Increased
69
Reduced
68
Closed
44
Calls
$6.78M
Puts
$3.42M
Net Calls
+$3.35M
Net Calls Change
-$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
KeyBank National Association
126
KeyBank National Association
Ohio
$161K +$82.5K +15,216 +88%
PWM
127
Prosperity Wealth Management
California
$158K +$172K +31,800 New
AB
128
Amalgamated Bank
New York
$153K
Handelsbanken Fonder
129
Handelsbanken Fonder
Sweden
$140K +$61.8K +11,400 +68%
Stifel Financial
130
Stifel Financial
Missouri
$139K -$344K -63,477 -69%
CG
131
Cutler Group
California
$136K +$41.3K +7,613 +38%
AC
132
AXQ Capital
New Jersey
$136K +$148K +27,336 New
CAPTRUST Financial Advisors
133
CAPTRUST Financial Advisors
North Carolina
$135K +$148K +27,308 New
Citadel Advisors
134
Citadel Advisors
Florida
$132K -$7.67M -1,413,786 -98%
AQR Capital Management
135
AQR Capital Management
Connecticut
$130K
GTCM
136
Gyon Technologies Capital Management
New Jersey
$129K +$78.2K +14,422 +124%
PAMS
137
Pictet Asset Management (Switzerland)
Switzerland
$128K +$52.6K +9,709 +60%
XT
138
XTX Topco
Cayman Islands
$125K +$136K +25,127 New
Victory Capital Management
139
Victory Capital Management
Texas
$123K -$60 -11 -0%
MAWCM
140
Mine & Arao Wealth Creation & Management
California
$110K
CPIG
141
Chicago Partners Investment Group
Illinois
$107K -$2.1K -388 -2%
ACM
142
Acrisure Capital Management
Texas
$101K +$110K +20,320 New
FIM
143
Freedom Investment Management
Connecticut
$92.3K -$5.59K -1,032 -5%
TFM
144
TFC Financial Management
Massachusetts
$89K
Northwestern Mutual Wealth Management
145
Northwestern Mutual Wealth Management
Wisconsin
$83.1K -$1.02K -189 -1%
SC
146
Scotia Capital
Ontario, Canada
$80.4K
Connor, Clark & Lunn Investment Management (CC&L)
147
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$78.2K +$85.5K +15,773 New
GAM
148
Gotham Asset Management
New York
$77.7K -$11 -2 -0%
E
149
Ergoteles
New York
$77.3K +$84.5K +15,582 New
AIP
150
Ameritas Investment Partners
Nebraska
$72.9K

IMGN Hedge Fund Activity: Q4 2022 in Review

204 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2022, worth a combined $1B — up 5.8% from $948M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IMGN and 27 opened new positions — a net loss of 17 holders — while 68 trimmed existing stakes and 69 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $27.3M. The largest seller was Deerfield Management, cutting an estimated $40M.

  • 204 institutional investors held Immunogen Inc (IMGN) as of Q4 2022, down from 222 in Q3 2022.
  • Funds reported $1B of Immunogen Inc stock for Q4 2022, up 5.8% quarter-over-quarter.
  • 27 funds opened new Immunogen Inc positions in Q4 2022 and 44 closed out, a net change of -17 holders.
  • The largest Immunogen Inc buyer in Q4 2022 was Woodline Partners, an estimated $27.3M added.
  • The largest Immunogen Inc seller in Q4 2022 was Deerfield Management, an estimated $40M sold.

Based on aggregated 13F filings for Q4 2022.